<DOC>
	<DOC>NCT00471224</DOC>
	<brief_summary>This protocol intends to detail investigations necessary to evaluate the ocular safety of subjects enrolled in study A4321001 and who have received formulated Drug Product (Lot 8716-098).</brief_summary>
	<brief_title>A Prospective Safety Follow Up Study Of Subjects Enrolled In Study A4321001 And Who Have Received Drug Product</brief_title>
	<detailed_description />
	<mesh_term>Siderosis</mesh_term>
	<criteria>A subset of subjects enrolled in study A4321001 and who have received formulated drug product (Lot 8716098) will be included in the safety follow up study.</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>February 2011</verification_date>
</DOC>